| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44ffdfd126f60306369329b25ba65d4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33368adde3981c339570de7cdebee62a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63c1ee545f0188ae4e7689fe478290f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f30828e0358ee953624783c7a97ccaeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8b5fba2a7557a05b3221c70475f0eb5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
2009-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0b37cd9e98b2d47107f1d3931b3c746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b82752e4952632e80d5f2e6e52f8ab2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aa70d6a2b873a08740efd1051e6a7bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58f64643790d3ba1b245319e367d51b9 |
| publicationDate |
2013-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8618133-B2 |
| titleOfInvention |
Aralkyl alcohol pyridine derivative compounds and the use thereof as medicaments for treating depression |
| abstract |
The present invention relates to an aralkyl alcohol piperidine derivative and use as antidepressant thereof. The said aralkyl alcohol piperidine derivative has a triple inhibition effect on the reuptaking of 5-HT, NA and DA. The derivative may be administered to the patient in need of such treatment in the form of composition by oral administration, injection and the like. The derivative is a compound having the following general formula or its salt: |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018155283-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11498896-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10752588-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10633336-B2 |
| priorityDate |
2008-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |